Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer

References

• Tang KT, Lee CH. BRAF mutation in papillary thyroid carcinoma: Pathogenic role and clinical implications. J Chin Med Assoc. 2010;73:113–28.
   PubMed Web of Science ®Google Scholar
• Kwak JY, Kim EK, Kim JK, Han JH, Hong SW, Park TS, . Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area. Head Neck. 2010;32:490–8.
   PubMed Web of Science ®Google Scholar
• Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, . Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg. 2005;71:874–8.
   PubMed Web of Science ®Google Scholar
• Lal G, Clark OH. Chronic thyroiditis. Textbook of endocrine: Surgery. Philadelphia: Saunders; 2005.
   Google Scholar
• Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP. Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: Impact on presentation, management, and outcome. Surgery. 1999;126:1070–6; discussion 1076–7.
   PubMed Web of Science ®Google Scholar
• Kumar V, Robbins SL. The endocrine system. Robbins basic pathology. Philadelphia: Saunders/Elsevier; 2007.
   Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
   PubMed Web of Science ®Google Scholar
• Dailey M, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg. 1955;70:291–7.
   PubMedGoogle Scholar
• Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601–4.
   PubMed Web of Science ®Google Scholar
• Crile GJ. Struma lymphomatosa and carcinoma of the thyroid. Surg Gynecol Obstet. 1978;147:350–2.
   PubMedGoogle Scholar
• Shands WC. Carcinoma of the thyroid in association with struma lymphomatosa (Hashimoto’s disease). Ann Surg. 1960;151:675–82.
   PubMed Web of Science ®Google Scholar
• Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, . Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2009;71: 581–6.
   PubMed Web of Science ®Google Scholar
• Sanders LE, Cady B. Differentiated thyroid cancer: Reexamination of risk groups and outcome of treatment. Arch Surg. 1998;133:419–25.
   PubMedGoogle Scholar
• Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050–7.
   PubMed Web of Science ®Google Scholar
• Shim YS, Lee YS, Lee GH, Lee BC, Jung YW, Lee JW, . Clinical assessment and management of papillary thyroid carcinoma with coexistent Hashimoto’s thyroiditis. Korean J Otolaryngol – Head Neck Surg. 2007;50:537–1.
   Google Scholar
• Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, . Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg. 2007;204:764–73.
   PubMed Web of Science ®Google Scholar
• Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H. Is Hashimoto’s thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008;150:49–52.
   PubMed Web of Science ®Google Scholar
• Pisanu A, Piu S, Cois A, Uccheddu A. Coexisting Hashimoto’s thyroiditis with differentiated thyroid cancer and benign thyroid diseases: Indications for thyroidectomy. Chir Ital. 2003;55:365–72.
   PubMedGoogle Scholar
• Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, . Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid. 1998;8:197–202.
   PubMed Web of Science ®Google Scholar
• Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 1999;84:458–63.
   PubMed Web of Science ®Google Scholar
• McConahey WM. Hashimoto’s thyroiditis. Med Clin North Am. 1972;56:885–96.
   PubMedGoogle Scholar
• Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, . Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope. 1997;107:95–100.
   PubMed Web of Science ®Google Scholar
• Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, . Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis. Science. 1997;275:960–3.
   PubMed Web of Science ®Google Scholar
• Kimura H, Yamashita S, Namba H, Tominaga T, Tsuruta M, Yokoyama N, . Interleukin-1 inhibits human thyroid carcinoma cell growth. J Clin Endocrinol Metab. 1992;75: 596–602.
   PubMed Web of Science ®Google Scholar
• Kim SK, Song KH, Lim SD, Lim YC, Yoo YB, Kim JS, . Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid. 2009;19:137–41.
   PubMed Web of Science ®Google Scholar